1 Statement of Work: Patient Portal Development STATEMENT OF WORK THIS AGREEMENT (“Statement of Work” or “SOW”) dated January 18, 2024 , is between Acme, LLC (“Consultant” or “Acme”) and BigPharma Corporation (“Client” or “BigPharma” ). This Statement of Work is controlled by the terms and conditions set forth in the Master Services Agreement (“Agreement”) betw een the aforementioned parties dated October 13, 2021 , which references the following terms: Description of Services and Deliverables BigPharma currently utilizes a suite of product -specific web portals to interact with patients and provide critical information . These portals use a variety of technical stacks and approaches to solve similar problems and include proprietary packages and dependencies on various marketing vendors. BigPharma ’ IT practice wishes to consolidate the technical approaches to developing these portal sites and leverage the streamlined tooling ASP.NET Core Blazor to provide a richer, patient -focused solution to support the business. Shared libraries will be created t o standardiz e and enable the reuse of components through the patient portals. The team will utilize lessons learned from developing streamlined tooling approaches for marketing sites. Acme agrees to work with BigPharma’ IT team to design, deve lop, and document this portal development . Acme shall ensure that any deliverables, including any strategy guidance etc., related to BigPharma’ websites or other digital assets will conform to BigPharma standards for web accessibilit y and compliance (e.g. WCAG 2.1 level AA) (“Access Standard”) unless otherwise agreed by BigPharma in writing. Conformance to the Access Standard shall be considered to be a condition of acceptance for any deliverables where such Access Standard is applicable. Acme agrees to provide the following services and deliverables: DocuSign Envelope ID: 8B61DCE2-9EEB-4FAE-9E0F-67D6AEA12BF3D e liv e rable s :  Quality assurance -tested code .  Technical designs, user interface mockups, and other development artifacts .  Bi-Weekly Status Reports .  Weekly Code Review Meeting s. Ser v ices :  Collaborate with business analysts, business stakeholders, and other developers to ensure that the technical requirements for development backlog items are correctly elaborated, documented, and understood.  Estimate future backlog development items with other developers using story points and agreed -to point scales .  Conduct quality assurance testing for completed development items, including unit , automated , and integration testing .  Utilize BigPharma DevOps platforms to manage code re pository and branching strategy to ensure a clean, current codebase .  Utilize BigPharma Auth0 security platform to manage authentication and migration of patient portal information .  Manage work items in BigPharma’ instance of Azure DevOps, including tracking metrics, using dashboards, and forecasting delivery for future sprints .  Contribute to overall team deliverables , including status reports, sprint reviews, etc. Delivery Schedule This engagement will begin within 90 days of execut ing the Statement of Work. Acme will provide one (1) full-stack developer for an estimated eight (8) months . Delivery of specific scope features will vary based on prioritization by BigPharma business and estimation by developers. Delivery Schedules are estimates only, as completion dates assume the start date specified by this SOW and the correctness o f assumptions detailed in this document and in discussions with BigPharma . The start and finish dates are flexible and are not critical to the success of the project. Investment Acme will provide the services and deliverables described above at a Monthly per -Consultant rate of $24,000. Acme agrees to perform all services based on Client instruction, Client priority, and available time; however, this does not guarantee completion or delivery of any functionality or schedule. For monthly fla t-rate billing, Consultants typically work 40 hours per week, with variances to ensure delivery when necessary consistent with Acme’s Results -Focused culture. Consultant vacations less than a period of 10 business days are not deducted from invoicing ra tes. Hours over 55 per week per Consultant, regularly outside typical working hours, or weekend hours will be billed on a Time and Materials, Overtime rate of $300 per hour per Consultant. Acme will send invoices at the conclusion of each month to jwmjisg@test.com with Tony Smith on copy at awzlwiv@test.com .  DocuSign Envelope ID: 8B61DCE2-9EEB-4FAE-9E0F-67D6AEA12BF3Should any Consultant be regularly required to work outside of core business hours (Mon day-Friday 8am -6pm) as part of their project, Acme will invoice an additional $300 per day per Consultant hazard fee. Based on the monthly per -Consultant rate with contingency, the estimated cost to BigPharma is $192,000 . Project Constraints and Flexibility Any project must always balance three types of project constraints: Scope, Cost, and Time. Acme agrees to perform all services based on Client instruction, Client priority, and available time. Client acknowledges that priorit izing two of the project constraints will necessitate flexibility on the third . Expiration This contract will expire if not executed by Client and received by Acme by March 29th, 2024 . Travel Expenses If Consultant is engaged to work outside of the ir home metropolitan area, Client agrees to pay for actual and reasonable costs incurred by Acme for travel, living, and boarding, provided anticipated expenses are in accordance with Client’s travel policy. Acme will render invoices for expenses upo n completion of the services or monthly, in the event the duration of services exceeds one month. Invoices for expenses are payable upon receipt. Assumptions  All changes and change requests outside the defined Description of Services and Deliverables of th is Statement of Work (i) will be accomplished in writing, (ii) will be executed by both parties, and (iii) may have cost and schedule implications if agreed upon in writing by Client . Acme will detail any changes to cost and schedule resulting from such changes in an executed Request for Change or SOW.  Client will provide a team member who will take on the primary responsibilities for applicable project management, including status reporting, sprint review materials, etc.  Client will share any availabl e previous vendor documentation and architecture related to the software applications in scope for the Acme Consultants.  Client will provide reasonable access to key personnel in a timely fashion.  Client will provide guidance as to budgetary and licen sing restrictions for tool selection.  Client is responsible for providing a technological and processing environment conducive to supporting the system selected by Client and in accordance with the specifications recommended by the software publisher.  Client assumes complete responsibility for the selection, licensing and performance of all hardware and software. Consultant makes no claim, and accepts no responsibility whatsoever, as to the suitability of such hardware and software applications for Client’ s business operations and objective.  Client will provide a development and testing environment for integration with other systems. If Client cannot provide such an environment, Client will accept any loss of productivity on production environments due to d evelopment, testing, deployment, and support of software on these systems. DocuSign Envelope ID: d6a2e2af-0740-44b4-b9fa-34657b0575b3 Acme is not liable for changes to Client’s third -party systems, or the data therein, while working in conjunction with the respective vendors of each system.  Client will provide a VPN connection to allow Acme to connect to their network remotely.  Acme expects and plans to perform all services in a continuous manner. Delays mandated by Client will have cost and schedule implications. Acme will detail any changes to cost a nd schedule resulting from such slippage in an executed Request for Change.  Acme will deem all data provided by the Client for development and testing purposes as not personally identifiable as described by GLBA and HIPAA, unless Client formally notifie s Acme otherwise.  Client will encrypt and specifically label any data that any Federal or State act protects before providing such data to Acme for development and testing purposes.  Client will have five (5) contiguous business days to review provided deliverables and notify Acme of acceptance or required changes. If Client does not notify Acme within five (5) contiguous business days, Client will have accepted the deliverable.  Formal training is outside the scope of this SOW.  Acme will perform the Services and Deliverables in a professional and workmanlike manner, consistent with industry standards and in accordance with the Agreement . IN WITNESS THEREOF, the parties have executed this Statement of Work as of this ____ day of _ _____ _____, 2024 . Acme , LLC BigPharma Corporation By: ____________________________ ________ By: _____________________________ __________ Name: _ ______________________ __________ Name: _ ______________________________ ____ Title: _________________________ _____ _____ Title: ________________________________ _____ DocuSign Envelope ID: c62b4ffc-4435-458f-ba2c-f11f8548c395 Elon Musk CEO VP, CIO13th John JacksonFebruary